A recent retrospective study of brain and spinal MRI of patients suspected or known to have multiple sclerosis showed that the introduction of a structured reporting template produced reports with more adequate information for clinical decision making. The results were published in the American Journal of Roentgenology

Cancer risks can fluctuate depending on where you live, what you eat, what’s in your genes and what you do for work. Now, according to new research, when you work may also have an impact. A meta-analysis in Cancer Epidemiology, Biomarkers & Prevention found that women working night shifts face a 19 percent higher risk of cancer, including breast, skin, and gastrointestinal varieties.

GE Healthcare has entered into a strategic, long-term partnership with Roche to jointly develop and co-market digital clinical decision support solutions. The partnership will initially focus on products that accelerate and improve individualized treatment options for cancer and critical care patients.

Head trauma and sports—most notably football but also hockey, soccer and boxing—have been the focus of plenty of media coverage. Recent studies have shown an overwhelming majority of deceased football player’s brains contained evidence of chronic traumatic encephalopathy, or CTE.

A Children’s National Health System team has found velocity-selective arterial spin labeling (VSASL), an advanced MRI technology, can detect early signs of global placental perfusion in pregnancies complicated by fetal congenital heart disease (CHD).

Teams at 21 locations across the country are using MRI to study 10,000 children from the time they are 9 or 10 years old into young adulthood. Now, according to Science magazine, the researchers will release data for 4,500 participants in an openly accessible, anonymized database.

PET is already considered the most sensitive non-surgical techniques for studying physiology, metabolism and molecular pathways, but experts believe recent developments may drastically increase its capabilities.

Researchers have developed a new MRI technology that allows patients with suspected kidney tumors to bypass biopsies. A recent study, led by Ivan Pedrosa, MD and Jeffrey Cadeddu, MD with the Kidney Cancer Program at the University of Texas Southwestern Harold C. Simmons Comprehensive Cancer Center, was published online Jan. 2 in The Journal of Urology.